SEK 0.04
(-1.92%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 42.34 Million SEK | -7.47% |
2022 | 45.75 Million SEK | 27.65% |
2021 | 35.84 Million SEK | 11.89% |
2020 | 32.03 Million SEK | -4.26% |
2019 | 33.46 Million SEK | 30.66% |
2018 | 25.61 Million SEK | 51.67% |
2017 | 16.88 Million SEK | 100.84% |
2016 | 8.4 Million SEK | 51.37% |
2015 | 5.55 Million SEK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 90.86 Million SEK | 125.77% |
2024 Q1 | 40.24 Million SEK | -4.94% |
2023 Q1 | 85.78 Million SEK | 87.47% |
2023 FY | 42.34 Million SEK | -7.47% |
2023 Q4 | 42.34 Million SEK | 2.99% |
2023 Q3 | 41.11 Million SEK | -71.96% |
2023 Q2 | 146.6 Million SEK | 70.91% |
2022 Q2 | 43.98 Million SEK | 4.16% |
2022 Q4 | 45.75 Million SEK | 3.54% |
2022 Q1 | 42.23 Million SEK | 17.82% |
2022 FY | 45.75 Million SEK | 27.65% |
2022 Q3 | 44.19 Million SEK | 0.47% |
2021 Q4 | 35.84 Million SEK | -22.93% |
2021 Q2 | 65.23 Million SEK | 71.69% |
2021 Q1 | 37.99 Million SEK | 18.61% |
2021 FY | 35.84 Million SEK | 11.89% |
2021 Q3 | 46.51 Million SEK | -28.71% |
2020 Q4 | 32.03 Million SEK | -11.27% |
2020 Q3 | 36.1 Million SEK | 9.94% |
2020 Q2 | 32.83 Million SEK | 7.1% |
2020 Q1 | 30.66 Million SEK | -8.36% |
2020 FY | 32.03 Million SEK | -4.26% |
2019 Q3 | 21.53 Million SEK | -15.14% |
2019 FY | 33.46 Million SEK | 30.66% |
2019 Q2 | 25.37 Million SEK | 20.75% |
2019 Q4 | 33.46 Million SEK | 55.4% |
2019 Q1 | 21.01 Million SEK | -17.94% |
2018 Q1 | - SEK | -100.0% |
2018 FY | 25.61 Million SEK | 51.67% |
2018 Q4 | 25.61 Million SEK | -23.36% |
2018 Q3 | 33.41 Million SEK | -4.06% |
2018 Q2 | 34.83 Million SEK | 0.0% |
2017 Q1 | - SEK | 0.0% |
2017 FY | 16.88 Million SEK | 100.84% |
2017 Q4 | 16.88 Million SEK | 0.0% |
2016 FY | 8.4 Million SEK | 51.37% |
2015 FY | 5.55 Million SEK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
AddLife AB (publ) | 7.78 Billion SEK | 99.456% |
Biotage AB (publ) | 1.27 Billion SEK | 96.677% |
Bonesupport Holding AB (publ) | 143.63 Million SEK | 70.523% |
Doxa AB (publ) | 280.8 Million SEK | 84.922% |
Elekta AB (publ) | 21.61 Billion SEK | 99.804% |
iZafe Group AB (publ) | 9.26 Million SEK | -357.186% |
Ortivus AB (publ) | 55.4 Million SEK | 23.575% |
Ortivus AB (publ) | 55.4 Million SEK | 23.575% |
S2Medical AB (publ) | 19.74 Million SEK | -114.386% |
Synsam AB (publ) | 5.52 Billion SEK | 99.233% |